• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Jaundice: an important, poorly recognized risk factor for diminished survival in patients with adenocarcinoma of the head of the pancreas.黄疸:一种重要但未被充分认识的风险因素,可降低头颈部胰腺腺癌患者的生存。
HPB (Oxford). 2014 Feb;16(2):150-6. doi: 10.1111/hpb.12094. Epub 2013 Apr 22.
2
Duration of Preoperative Biliary Drainage as a Prognostic Factor After Pancreaticoduodenectomy for Pancreatic Head Cancer.术前胆道引流时间作为胰头癌胰十二指肠切除术后的一个预后因素
Anticancer Res. 2017 Jun;37(6):3215-3219. doi: 10.21873/anticanres.11683.
3
Self-expanding metal stents (SEMS) for preoperative biliary decompression in patients with resectable and borderline-resectable pancreatic cancer: outcomes in 241 patients.可切除和交界可切除胰腺癌患者术前胆道减压用自膨式金属支架(SEMS):241 例患者的结局。
Dig Dis Sci. 2013 Jun;58(6):1744-50. doi: 10.1007/s10620-012-2482-z. Epub 2012 Nov 21.
4
Resected adenocarcinoma of the pancreas-616 patients: results, outcomes, and prognostic indicators.胰腺切除腺癌——616例患者:结果、转归及预后指标
J Gastrointest Surg. 2000 Nov-Dec;4(6):567-79. doi: 10.1016/s1091-255x(00)80105-5.
5
Management of patients with obstructive jaundice: experience in a developing country.阻塞性黄疸患者的管理:一个发展中国家的经验
Nig Q J Hosp Med. 2011 Jan-Mar;21(1):75-9.
6
Severe Jaundice Increases Early Severe Morbidity and Decreases Long-Term Survival after Pancreaticoduodenectomy for Pancreatic Adenocarcinoma.严重黄疸增加胰腺腺癌胰十二指肠切除术后早期严重并发症发生率并降低长期生存率。
J Am Coll Surg. 2015 Aug;221(2):380-9. doi: 10.1016/j.jamcollsurg.2015.03.058. Epub 2015 Apr 14.
7
Preoperative serum C-reactive protein levels and post-operative lymph node ratio are important predictors of survival after pancreaticoduodenectomy for pancreatic ductal adenocarcinoma.术前血清C反应蛋白水平和术后淋巴结比率是胰腺导管腺癌胰十二指肠切除术后生存的重要预测指标。
JOP. 2012 Mar 10;13(2):199-204.
8
Preoperative resolution of jaundice following biliary stenting predicts more favourable early survival in resected pancreatic ductal adenocarcinoma.胆管支架置入术后黄疸的术前消退预示着切除的胰腺导管腺癌患者早期生存率更高。
Ann Surg Oncol. 2008 Nov;15(11):3138-46. doi: 10.1245/s10434-008-0148-z. Epub 2008 Sep 12.
9
Preoperative biliary stenting versus operation first in jaundiced patients due to malignant lesions in the pancreatic head: A meta-analysis of current literature.胰头恶性病变所致黄疸患者术前胆道支架置入与先行手术治疗的比较:当前文献的荟萃分析
Surgery. 2017 Apr;161(4):939-950. doi: 10.1016/j.surg.2016.11.001. Epub 2016 Dec 30.
10
Para-aortic node involvement is not an independent predictor of survival after resection for pancreatic cancer.主动脉旁淋巴结受累并非胰腺癌切除术后生存的独立预测因素。
World J Gastroenterol. 2017 Jun 28;23(24):4399-4406. doi: 10.3748/wjg.v23.i24.4399.

引用本文的文献

1
Impact of preoperative biliary drainage on outcomes of pancreaticoduodenectomy in severe hyperbilirubinemia.术前胆道引流对重度高胆红素血症患者胰十二指肠切除术预后的影响。
Surg Endosc. 2025 Aug 13. doi: 10.1007/s00464-025-12027-2.
2
OUTCOMES OF PATIENTS UNDERGOING PANCREATODUODENECTOMY (WHIPPLE'S PROCEDURE) ACCORDING TO THE PRESENCE OF PREOPERATIVE BILIARY DRAINAGE.根据术前胆道引流情况,接受胰十二指肠切除术(惠普尔手术)患者的预后
Arq Gastroenterol. 2025 Jul 21;62:e24089. doi: 10.1590/S0004-2803.24612024-089. eCollection 2025.
3
Palliative management for malignant biliary obstruction and gastric outlet obstruction from pancreatic cancer.胰腺癌所致恶性胆道梗阻和胃出口梗阻的姑息治疗
Ann Gastroenterol Surg. 2024 Dec 26;9(2):218-225. doi: 10.1002/ags3.12902. eCollection 2025 Mar.
4
Impact of Routine and Selective Preoperative Endoscopic Retrograde Cholangiopancreatography with Stent Placement on Postoperative and Oncologic Outcomes Following Pancreaticoduodenectomy for Pancreatic Ductal Adenocarcinoma.常规及选择性术前内镜逆行胰胆管造影术并支架置入对胰腺导管腺癌胰十二指肠切除术后及肿瘤学结局的影响
Biomedicines. 2025 Feb 1;13(2):333. doi: 10.3390/biomedicines13020333.
5
Advances in Endoscopic Ultrasound in Pancreatic Cancer Screening, Diagnosis, and Palliative Care.胰腺癌筛查、诊断及姑息治疗中内镜超声的进展
Biomedicines. 2024 Dec 31;13(1):76. doi: 10.3390/biomedicines13010076.
6
An integrative multi-omics analysis reveals a multi-analyte signature of pancreatic ductal adenocarcinoma in serum.一项综合多组学分析揭示了血清中胰腺导管腺癌的多分析物特征。
J Gastroenterol. 2025 Apr;60(4):496-511. doi: 10.1007/s00535-024-02197-6. Epub 2024 Dec 12.
7
Pancreatic cancer symptom trajectories from Danish registry data and free text in electronic health records.从丹麦登记数据和电子健康记录中的自由文本中提取的胰腺癌症状轨迹。
Elife. 2023 Nov 21;12:e84919. doi: 10.7554/eLife.84919.
8
Principles of Palliative and Supportive Care in Pancreatic Cancer: A Review.胰腺癌姑息与支持治疗原则:综述
Biomedicines. 2023 Oct 1;11(10):2690. doi: 10.3390/biomedicines11102690.
9
Characteristics Associated With Survival in Surgically Nonresected Pancreatic Adenocarcinoma in the Military Health System.与军事卫生系统中行手术非切除术的胰腺腺癌生存相关的特征。
Am J Clin Oncol. 2024 Feb 1;47(2):64-70. doi: 10.1097/COC.0000000000001057. Epub 2023 Oct 17.
10
Artificial Intelligence in Endoscopic Ultrasonography-Guided Fine-Needle Aspiration/Biopsy (EUS-FNA/B) for Solid Pancreatic Lesions: Opportunities and Challenges.人工智能在内镜超声引导下对实性胰腺病变进行细针穿刺抽吸/活检(EUS-FNA/B):机遇与挑战
Diagnostics (Basel). 2023 Sep 26;13(19):3054. doi: 10.3390/diagnostics13193054.

本文引用的文献

1
Factors affecting long-term survival after surgical resection of pancreatic ductal adenocarcinoma.影响胰腺导管腺癌手术切除后长期生存的因素。
J Korean Surg Soc. 2011 Dec;81(6):394-401. doi: 10.4174/jkss.2011.81.6.394. Epub 2011 Nov 25.
2
Obstructive jaundice expands intrahepatic regulatory T cells, which impair liver T lymphocyte function but modulate liver cholestasis and fibrosis.阻塞性黄疸会导致肝内调节性 T 细胞扩张,从而损害肝内淋巴细胞功能,但可调节肝内胆汁淤积和纤维化。
J Immunol. 2011 Aug 1;187(3):1150-6. doi: 10.4049/jimmunol.1004077. Epub 2011 Jun 22.
3
Therapeutic delay and survival after surgery for cancer of the pancreatic head with or without preoperative biliary drainage.术前胆道引流与否对胰头癌手术治疗后治疗延误和生存的影响。
Ann Surg. 2010 Nov;252(5):840-9. doi: 10.1097/SLA.0b013e3181fd36a2.
4
A single institution review of adjuvant therapy outcomes for resectable pancreatic adenocarcinoma: outcome and prognostic indicators.单中心可切除胰腺腺癌辅助治疗结果回顾:结果和预后指标。
J Gastrointest Surg. 2010 Jul;14(7):1159-69. doi: 10.1007/s11605-010-1213-z. Epub 2010 May 6.
5
Immunosuppression in the livers of mice with obstructive jaundice participates in their susceptibility to bacterial infection and tumor metastasis.梗阻性黄疸小鼠肝脏的免疫抑制参与了其对细菌感染和肿瘤转移的易感性。
Shock. 2010 May;33(5):500-6. doi: 10.1097/SHK.0b013e3181c4e44a.
6
Preoperative resolution of jaundice following biliary stenting predicts more favourable early survival in resected pancreatic ductal adenocarcinoma.胆管支架置入术后黄疸的术前消退预示着切除的胰腺导管腺癌患者早期生存率更高。
Ann Surg Oncol. 2008 Nov;15(11):3138-46. doi: 10.1245/s10434-008-0148-z. Epub 2008 Sep 12.
7
Prognostic relevance of lymph node ratio following pancreaticoduodenectomy for pancreatic cancer.胰腺癌胰十二指肠切除术后淋巴结比率的预后相关性。
Surgery. 2007 May;141(5):610-8. doi: 10.1016/j.surg.2006.12.013. Epub 2007 Mar 23.
8
Phagocytosis and production of H2O2 by human peripheral blood mononuclear cells from patients with obstructive jaundice.阻塞性黄疸患者外周血单个核细胞的吞噬作用及过氧化氢生成
Pancreatology. 2006;6(4):273-8. doi: 10.1159/000092688. Epub 2006 Apr 19.
9
Pancreaticoduodenectomy: a 20-year experience in 516 patients.胰十二指肠切除术:516例患者的20年经验
Arch Surg. 2004 Jul;139(7):718-25; discussion 725-7. doi: 10.1001/archsurg.139.7.718.
10
Prognostic factors in resected pancreatic adenocarcinoma: analysis of actual 5-year survivors.切除的胰腺腺癌的预后因素:对实际5年生存者的分析。
J Am Coll Surg. 2004 May;198(5):722-31. doi: 10.1016/j.jamcollsurg.2004.01.008.

黄疸:一种重要但未被充分认识的风险因素,可降低头颈部胰腺腺癌患者的生存。

Jaundice: an important, poorly recognized risk factor for diminished survival in patients with adenocarcinoma of the head of the pancreas.

机构信息

Section of Hepato-Pancreato-Biliary Surgery, Department of Surgery, Washington University in St Louis, St Louis, MO, USA; Alvin J. Siteman Cancer Center, Washington University in St Louis, St Louis, MO, USA.

出版信息

HPB (Oxford). 2014 Feb;16(2):150-6. doi: 10.1111/hpb.12094. Epub 2013 Apr 22.

DOI:10.1111/hpb.12094
PMID:23600768
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3921010/
Abstract

OBJECTIVES

Jaundice impairs cellular immunity, an important defence against the dissemination of cancer. Jaundice is a common mode of presentation in pancreatic head adenocarcinoma. The purpose of this study was to determine whether there is an association between preoperative jaundice and survival in patients who have undergone resection of such tumours.

METHODS

Thirty possible survival risk factors were evaluated in a database of over 400 resected patients. Univariate analysis was used to determine odds ratio for death. All factors for which a P-value of <0.30 was obtained were entered into a multivariate analysis using the Cox model with backward selection.

RESULTS

Preoperative jaundice, age, positive node status, poor differentiation and lymphatic invasion were significant indicators of poor outcome in multivariate analysis. Absence of jaundice was a highly favourable prognostic factor. Interaction emerged between jaundice and nodal status. The benefit conferred by the absence of jaundice was restricted to patients in whom negative node status was present. Five-year overall survival in this group was 66%. Jaundiced patients who underwent preoperative stenting had a survival advantage.

CONCLUSIONS

Preoperative jaundice is a negative risk factor in adenocarcinoma of the pancreas. Additional studies are required to determine the exact mechanism for this effect.

摘要

目的

黄疸会损害细胞免疫,这是抵抗癌症扩散的重要防御机制。黄疸是胰头腺癌的常见表现形式。本研究旨在确定在接受此类肿瘤切除的患者中,术前黄疸与生存之间是否存在关联。

方法

在超过 400 例接受切除手术的患者的数据库中,评估了 30 个可能的生存风险因素。使用单因素分析确定死亡的优势比。对于所有 P 值<0.30 的因素,使用 Cox 模型进行多因素分析,采用向后选择法。

结果

术前黄疸、年龄、阳性淋巴结状态、低分化和淋巴浸润是多因素分析中预后不良的显著指标。无黄疸是一个非常有利的预后因素。黄疸和淋巴结状态之间存在交互作用。无黄疸带来的益处仅限于淋巴结状态阴性的患者。该组患者的 5 年总生存率为 66%。接受术前支架置入术的黄疸患者具有生存优势。

结论

术前黄疸是胰腺腺癌的负风险因素。需要进一步研究以确定这种影响的确切机制。